The emergence and spread of SARS-Cov-2 Lambda (B.1.621) variant
The global death count resulting from the coronavirus disease 2019 (COVID-19) pandemic is 4.43 million. Thus, the need to maintain […]
Severe COVID-19 is associated with massive dysregulation of the host immune response, resulting in inflammation and the condition known as […] Researchers in Romania, the UK, and Canada have systematically reviewed the evidence available on the transmission of severe acute respiratory […] The World Health Organization (WHO) and the Swiss Confederation today signed a Memorandum of Understanding to launch the first WHO […] Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and […] COVID-19 (coronavirus disease 2019) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), displaying high mortality rates. Responsible for […] Researchers at UC Santa Cruz have developed a novel chip-based antigen test that can provide ultrasensitive detection of SARS-CoV-2 and […] Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] WASHINGTON (Reuters) – Director of National Intelligence Avril Haines said on Wednesday that U.S. intelligence agencies do not know exactly […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […]SARS
Human tissue xenografts in murine models for the study of SARS-CoV-2
Risk of SARS-CoV-2 transmission aboard aircraft is low: A review of evidence
WHO and Swiss Confederation launch Biohub facility to improve sharing and analysis of viruses
Plant-based vaccine against SARS-CoV-2 shows promise
A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity
Novel chip-based antigen test can provide ultrasensitive detection of SARS-CoV-2, influenza A
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
US: Spy Agencies Do Not Know Exactly When COVID First Transmitted
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents